These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

307 related items for PubMed ID: 31219646

  • 1. Macrophage migration inhibitory factor promotes the invasion and metastasis of oral squamous cell carcinoma through matrix metalloprotein-2/9.
    Wang SS, Zheng M, Pang X, Zhang M, Yu XH, Wu JB, Gao XL, Wu JS, Yang X, Tang YJ, Tang YL, Liang XH.
    Mol Carcinog; 2019 Oct; 58(10):1809-1821. PubMed ID: 31219646
    [Abstract] [Full Text] [Related]

  • 2. Transient transfection of macrophage migration inhibitory factor small interfering RNA disrupts the biological behavior of oral squamous carcinoma cells.
    Zeng J, Quan J, Xia X.
    Mol Med Rep; 2016 Jan; 13(1):174-80. PubMed ID: 26549761
    [Abstract] [Full Text] [Related]

  • 3. Upregulation of macrophage migration inhibitory factor promotes tumor metastasis and correlates with poor prognosis of pancreatic ductal adenocarcinoma.
    Wang D, Wang R, Huang A, Fang Z, Wang K, He M, Xia JT, Li W.
    Oncol Rep; 2018 Nov; 40(5):2628-2636. PubMed ID: 30226561
    [Abstract] [Full Text] [Related]

  • 4. Macrophage migration inhibitory factor is a novel prognostic marker for human oral squamous cell carcinoma.
    Kang Y, Zhang Y, Sun Y.
    Pathol Res Pract; 2018 Aug; 214(8):1192-1198. PubMed ID: 30041958
    [Abstract] [Full Text] [Related]

  • 5. N-myc downstream-regulated gene 1 downregulates cell proliferation, invasiveness, and tumorigenesis in human oral squamous cell carcinoma.
    Lee JC, Chung LC, Chen YJ, Feng TH, Juang HH.
    Cancer Lett; 2014 Dec 28; 355(2):242-52. PubMed ID: 25218595
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Prognostic role of macrophage migration inhibitory factor expression in patients with squamous cell carcinoma of the lung.
    Koh HM, Kim DC, Kim YM, Song DH.
    Thorac Cancer; 2019 Dec 28; 10(12):2209-2217. PubMed ID: 31602798
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. MUC1 gene silencing inhibits proliferation, invasion, and migration while promoting apoptosis of oral squamous cell carcinoma cells.
    Zhang AM, Chi XH, Bo ZQ, Huang XF, Zhang J.
    Biosci Rep; 2019 Sep 30; 39(9):. PubMed ID: 31439759
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Fatty-acid-binding protein 5 promotes cell proliferation and invasion in oral squamous cell carcinoma.
    Fang LY, Wong TY, Chiang WF, Chen YL.
    J Oral Pathol Med; 2010 Apr 30; 39(4):342-8. PubMed ID: 20040021
    [Abstract] [Full Text] [Related]

  • 17. CXCR4 promotes oral squamous cell carcinoma migration and invasion through inducing expression of MMP-9 and MMP-13 via the ERK signaling pathway.
    Yu T, Wu Y, Helman JI, Wen Y, Wang C, Li L.
    Mol Cancer Res; 2011 Feb 30; 9(2):161-72. PubMed ID: 21205837
    [Abstract] [Full Text] [Related]

  • 18. Interleukin-22 promotes the migration and invasion of oral squamous cell carcinoma cells.
    Komine-Aizawa S, Aizawa S, Takano C, Hayakawa S.
    Immunol Med; 2020 Sep 30; 43(3):121-129. PubMed ID: 32546118
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.